Article
Resistin gene variation is associated with systemic inflammation but not plasma adipokine levels, metabolic syndrome or coronary atherosclerosis in nondiabetic Caucasians.
Clinical endocrinology - 1 May 2009
Qasim Atif N, Metkus Thomas S, Tadesse Mahlet, Lehrke Michael, Restine Stephanie, Wolfe Megan L, Hannenhalli Sridhar, Cappola Thomas, Rader Daniel J, Reilly Muredach P
Abstract excerpt
OBJECTIVE: Resistin causes insulin resistance and diabetes in mice whereas in humans it is linked to inflammation and atherosclerosis. Few human genetic studies of resistin in inflammation and atherosclerosis have been performed. We hypothesized that the -420C>G putative gain-of-function resistin variant would be associated with inflammatory markers and atherosclerosis but not with metabolic syndrome or...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
